VTGN logo

VistaGen Therapeutics (VTGN) Non Current Assets

Annual Non Current Assets

$2.98 M
-$601.00 K-16.78%

31 March 2024

VTGN Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$2.55 M
-$162.00 K-5.98%

30 September 2024

VTGN Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VTGN Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.8%-18.3%
3 y3 years-28.4%-37.3%
5 y5 years+678.7%-37.2%

VTGN Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-28.4%at low-37.3%at low
5 y5 years-28.9%+678.7%-40.7%at low
alltimeall time-28.9%>+9999.0%-40.7%

VistaGen Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$2.55 M(-6.0%)
June 2024
-
$2.71 M(-9.1%)
Mar 2024
$120.67 M(+589.3%)
$2.98 M(+0.9%)
Dec 2023
-
$2.95 M(-5.3%)
Sept 2023
-
$3.12 M(-9.7%)
June 2023
-
$3.45 M(-3.6%)
Mar 2023
$17.51 M(-75.3%)
$3.58 M(-1.9%)
Dec 2022
-
$3.65 M(-3.6%)
Sept 2022
-
$3.79 M(+1.5%)
June 2022
-
$3.73 M(+2.4%)
Mar 2022
$71.00 M(-31.8%)
$3.65 M(-3.2%)
Dec 2021
-
$3.77 M(-7.3%)
Sept 2021
-
$4.06 M(-0.5%)
June 2021
-
$4.08 M(-2.0%)
Mar 2021
$104.12 M(+6488.9%)
$4.16 M(-2.6%)
Dec 2020
-
$4.28 M(-0.5%)
Sept 2020
-
$4.30 M(+7.8%)
June 2020
-
$3.99 M(-4.9%)
Mar 2020
$1.58 M(-88.4%)
$4.19 M(+6.2%)
Dec 2019
-
$3.95 M(-2.7%)
Sept 2019
-
$4.06 M(-2.6%)
June 2019
-
$4.17 M(+988.7%)
Mar 2019
$13.63 M(+23.6%)
$382.80 K(+0.0%)
Dec 2018
-
$382.70 K(-6.6%)
Sept 2018
-
$409.60 K(+0.7%)
June 2018
-
$406.80 K(+59.4%)
Mar 2018
$11.02 M(+226.3%)
$255.20 K(-5.7%)
Dec 2017
-
$270.60 K(-6.6%)
Sept 2017
-
$289.80 K(-6.7%)
June 2017
-
$310.70 K(-7.1%)
Mar 2017
$3.38 M
$334.30 K(+210.4%)
Dec 2016
-
$107.70 K(-7.9%)
DateAnnualQuarterly
Sept 2016
-
$117.00 K(-5.0%)
June 2016
-
$123.20 K(-8.4%)
Mar 2016
$855.30 K(+709.2%)
$134.50 K(+7.2%)
Dec 2015
-
$125.50 K(-7.1%)
Sept 2015
-
$135.10 K(-9.6%)
June 2015
-
$149.50 K(-8.8%)
Mar 2015
$105.70 K(+161.0%)
$164.00 K(-10.8%)
Dec 2014
-
$183.90 K(-6.6%)
Sept 2014
-
$197.00 K(-6.2%)
June 2014
-
$210.10 K(-5.9%)
Mar 2014
$40.50 K(-94.0%)
$223.20 K(-6.1%)
Dec 2013
-
$237.60 K(-5.7%)
Sept 2013
-
$252.00 K(+21.7%)
June 2013
-
$207.10 K(-1.2%)
Mar 2013
$671.80 K(+182.2%)
$209.70 K(-4.2%)
Dec 2012
-
$219.00 K(+127.7%)
Sept 2012
-
$96.20 K(-5.8%)
June 2012
-
$102.10 K(-1.4%)
Mar 2012
$238.10 K(>+9900.0%)
$103.50 K(-12.1%)
Dec 2011
-
$117.80 K(+11.9%)
Sept 2011
-
$105.30 K(-2.6%)
June 2011
-
$108.10 K(>+9900.0%)
Mar 2011
-
$300.00(-25.0%)
Dec 2010
$1800.00(+200.0%)
$400.00(-20.0%)
Sept 2010
-
$500.00(-16.7%)
June 2010
-
$600.00(-14.3%)
Mar 2010
-
$700.00(-12.5%)
Dec 2009
$600.00(-97.2%)
$800.00(-11.1%)
Sept 2009
-
$900.00(-10.0%)
June 2009
-
$1000.00(-16.7%)
Dec 2008
$21.80 K
$1200.00(>+9900.0%)
June 2008
-
$0.00(0.0%)
Mar 2008
-
$0.00

FAQ

  • What is VistaGen Therapeutics annual long term assets?
  • What is the all time high annual non current assets for VistaGen Therapeutics?
  • What is VistaGen Therapeutics annual non current assets year-on-year change?
  • What is VistaGen Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for VistaGen Therapeutics?
  • What is VistaGen Therapeutics quarterly non current assets year-on-year change?

What is VistaGen Therapeutics annual long term assets?

The current annual non current assets of VTGN is $2.98 M

What is the all time high annual non current assets for VistaGen Therapeutics?

VistaGen Therapeutics all-time high annual long term assets is $4.19 M

What is VistaGen Therapeutics annual non current assets year-on-year change?

Over the past year, VTGN annual long term assets has changed by -$601.00 K (-16.78%)

What is VistaGen Therapeutics quarterly long term assets?

The current quarterly non current assets of VTGN is $2.55 M

What is the all time high quarterly non current assets for VistaGen Therapeutics?

VistaGen Therapeutics all-time high quarterly long term assets is $4.30 M

What is VistaGen Therapeutics quarterly non current assets year-on-year change?

Over the past year, VTGN quarterly long term assets has changed by -$571.60 K (-18.32%)